Scott Fidel
Stock Analyst at Stephens & Co.
(0.59)
# 3,758
Out of 4,918 analysts
184
Total ratings
40%
Success rate
-10.16%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Scott Fidel
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ARDT Ardent Health | Reiterates: Overweight | $21 | $10.22 | +105.48% | 5 | May 20, 2025 | |
| ADUS Addus HomeCare | Reiterates: Overweight | $142 | $104.96 | +35.29% | 12 | Mar 12, 2025 | |
| PNTG The Pennant Group | Reiterates: Overweight | $38 | $22.07 | +72.18% | 18 | Mar 11, 2025 | |
| AMED Amedisys | Reiterates: Equal-Weight | $101 | $98.51 | +2.53% | 13 | Mar 4, 2025 | |
| UHS Universal Health Services | Maintains: Equal-Weight | $210 → $223 | $162.98 | +36.83% | 10 | Feb 28, 2025 | |
| ALHC Alignment Healthcare | Reiterates: Overweight | $17 | $12.97 | +31.07% | 5 | Jan 2, 2025 | |
| CNC Centene | Maintains: Equal-Weight | $75 → $73 | $25.91 | +181.74% | 9 | Dec 13, 2024 | |
| UNH UnitedHealth Group | Maintains: Overweight | $605 → $675 | $237.77 | +183.89% | 22 | Dec 5, 2024 | |
| PACS PACS Group | Maintains: Overweight | $48 → $31 | $10.62 | +191.90% | 4 | Nov 18, 2024 | |
| CI The Cigna Group | Reiterates: Overweight | $410 | $262.23 | +56.35% | 12 | Nov 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $163 → $167 | $151.75 | +10.05% | 9 | Oct 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $21 | $20.33 | +3.30% | 1 | Oct 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Equal-Weight | $250 | $247.26 | +1.11% | 7 | Oct 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $615 | $274.66 | +123.91% | 3 | Sep 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $105 | $108.53 | -3.25% | 10 | Aug 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Equal-Weight | $320 | $155.13 | +106.28% | 9 | Jul 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $95 → $122 | $158.09 | -22.83% | 10 | May 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $92 | $21.12 | +335.61% | 9 | Jan 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $280 | $356.97 | -21.56% | 9 | Nov 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $95 | $2.70 | +3,418.52% | 4 | Jun 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $2.25 → $1.5 | $3.74 | -59.84% | 3 | Nov 11, 2022 |
Ardent Health
May 20, 2025
Reiterates: Overweight
Price Target: $21
Current: $10.22
Upside: +105.48%
Addus HomeCare
Mar 12, 2025
Reiterates: Overweight
Price Target: $142
Current: $104.96
Upside: +35.29%
The Pennant Group
Mar 11, 2025
Reiterates: Overweight
Price Target: $38
Current: $22.07
Upside: +72.18%
Amedisys
Mar 4, 2025
Reiterates: Equal-Weight
Price Target: $101
Current: $98.51
Upside: +2.53%
Universal Health Services
Feb 28, 2025
Maintains: Equal-Weight
Price Target: $210 → $223
Current: $162.98
Upside: +36.83%
Alignment Healthcare
Jan 2, 2025
Reiterates: Overweight
Price Target: $17
Current: $12.97
Upside: +31.07%
Centene
Dec 13, 2024
Maintains: Equal-Weight
Price Target: $75 → $73
Current: $25.91
Upside: +181.74%
UnitedHealth Group
Dec 5, 2024
Maintains: Overweight
Price Target: $605 → $675
Current: $237.77
Upside: +183.89%
PACS Group
Nov 18, 2024
Maintains: Overweight
Price Target: $48 → $31
Current: $10.62
Upside: +191.90%
The Cigna Group
Nov 1, 2024
Reiterates: Overweight
Price Target: $410
Current: $262.23
Upside: +56.35%
Oct 28, 2024
Maintains: Overweight
Price Target: $163 → $167
Current: $151.75
Upside: +10.05%
Oct 22, 2024
Initiates: Overweight
Price Target: $21
Current: $20.33
Upside: +3.30%
Oct 9, 2024
Reiterates: Equal-Weight
Price Target: $250
Current: $247.26
Upside: +1.11%
Sep 5, 2024
Reiterates: Overweight
Price Target: $615
Current: $274.66
Upside: +123.91%
Aug 6, 2024
Reiterates: Overweight
Price Target: $105
Current: $108.53
Upside: -3.25%
Jul 25, 2024
Reiterates: Equal-Weight
Price Target: $320
Current: $155.13
Upside: +106.28%
May 1, 2024
Maintains: Equal-Weight
Price Target: $95 → $122
Current: $158.09
Upside: -22.83%
Jan 5, 2024
Upgrades: Overweight
Price Target: $92
Current: $21.12
Upside: +335.61%
Nov 10, 2023
Reiterates: Overweight
Price Target: $280
Current: $356.97
Upside: -21.56%
Jun 27, 2023
Reiterates: Overweight
Price Target: $95
Current: $2.70
Upside: +3,418.52%
Nov 11, 2022
Maintains: Equal-Weight
Price Target: $2.25 → $1.5
Current: $3.74
Upside: -59.84%